Bandaram Pharma Packtech intimated BSE of its board meeting scheduled for May 30, 2026.
The board will consider audited standalone and consolidated financial statements for Q4 and FY ending March 31, 2026.
The meeting will also review the corresponding audit reports for the quarter and year.
The intimation is made pursuant to SEBI LODR Regulation 29.